BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25566992)

  • 1. EMT Transition Alters Interstitial Fluid Flow-Induced Signaling in ERBB2-Positive Breast Cancer Cells.
    Tchafa AM; Ta M; Reginato MJ; Shieh AC
    Mol Cancer Res; 2015 Apr; 13(4):755-64. PubMed ID: 25566992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L; Xiang B; Muthuswamy SK
    Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK Signaling.
    Shah AD; Bouchard MJ; Shieh AC
    PLoS One; 2015; 10(11):e0142337. PubMed ID: 26560447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
    Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.
    Ngan E; Northey JJ; Brown CM; Ursini-Siegel J; Siegel PM
    J Cell Sci; 2013 May; 126(Pt 9):1981-91. PubMed ID: 23447672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism.
    Munson JM; Bellamkonda RV; Swartz MA
    Cancer Res; 2013 Mar; 73(5):1536-46. PubMed ID: 23271726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways.
    Sobolik T; Su YJ; Wells S; Ayers GD; Cook RS; Richmond A
    Mol Biol Cell; 2014 Mar; 25(5):566-82. PubMed ID: 24403602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.
    Seton-Rogers SE; Lu Y; Hines LM; Koundinya M; LaBaer J; Muthuswamy SK; Brugge JS
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1257-62. PubMed ID: 14739340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms.
    Kingsmore KM; Logsdon DK; Floyd DH; Peirce SM; Purow BW; Munson JM
    Integr Biol (Camb); 2016 Dec; 8(12):1246-1260. PubMed ID: 27775742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
    Yoon SO; Shin S; Lipscomb EA
    Cancer Res; 2006 Mar; 66(5):2732-9. PubMed ID: 16510594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.
    Tornillo G; Bisaro B; Camacho-Leal Mdel P; Galiè M; Provero P; Di Stefano P; Turco E; Defilippi P; Cabodi S
    Eur J Cell Biol; 2011; 90(2-3):237-48. PubMed ID: 20961652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB2-enhanced invasiveness of H-Ras MCF10A breast cells requires MMP-13 and uPA upregulation via p38 MAPK signaling.
    Yong HY; Kim IY; Kim JS; Moon A
    Int J Oncol; 2010 Feb; 36(2):501-7. PubMed ID: 20043086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
    Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
    Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation.
    Salt MB; Bandyopadhyay S; McCormick F
    Cancer Discov; 2014 Feb; 4(2):186-99. PubMed ID: 24302555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast cancer cells.
    Chen WC; Lai YA; Lin YC; Ma JW; Huang LF; Yang NS; Ho CT; Kuo SC; Way TD
    J Agric Food Chem; 2013 Dec; 61(48):11817-24. PubMed ID: 24236784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK; Lee JJ; Yang Y; You KH; Lee JH
    Carcinogenesis; 2008 Apr; 29(4):704-12. PubMed ID: 18258606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.